President Donald Trump signed an executive order imposing 100% tariffs on pharmaceutical products from countries and manufacturers without trade agreements with the United States. The tariffs are set to take effect within the next several months, according to the White House.
The executive order represents a significant escalation in trade policy that could dramatically affect prescription drug pricing and availability in the U.S. market. The policy targets imports from a subset of countries, though the specific nations and criteria for inclusion were not detailed in the available reporting.